Deutsche Bank AG Invests $2.06 Million in Addus HomeCare Corporation $ADUS

Deutsche Bank AG bought a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) in the second quarter, Holdings Channel.com reports. The fund bought 20,523 shares of the company’s stock, valued at approximately $2,062,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Oregon Public Employees Retirement Fund boosted its position in Addus HomeCare by 2.5% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock valued at $446,000 after buying an additional 103 shares during the period. ProShare Advisors LLC increased its position in shares of Addus HomeCare by 3.1% during the fourth quarter. ProShare Advisors LLC now owns 3,527 shares of the company’s stock worth $379,000 after acquiring an additional 105 shares during the period. CANADA LIFE ASSURANCE Co boosted its holdings in shares of Addus HomeCare by 0.6% in the second quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock valued at $2,150,000 after purchasing an additional 106 shares during the period. State of Wyoming grew its stake in Addus HomeCare by 25.7% in the fourth quarter. State of Wyoming now owns 523 shares of the company’s stock worth $56,000 after purchasing an additional 107 shares in the last quarter. Finally, Pathstone Holdings LLC grew its stake in Addus HomeCare by 0.9% in the third quarter. Pathstone Holdings LLC now owns 12,727 shares of the company’s stock worth $1,502,000 after purchasing an additional 112 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

ADUS has been the subject of a number of research analyst reports. Citizens Jmp reaffirmed a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th. Royal Bank Of Canada increased their price target on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Citigroup reaffirmed a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Finally, Barclays increased their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and a consensus price target of $130.88.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $115.55 on Friday. Addus HomeCare Corporation has a 12-month low of $87.95 and a 12-month high of $124.43. The business’s fifty day simple moving average is $111.95 and its 200-day simple moving average is $102.96. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. The company has a market cap of $2.16 billion, a PE ratio of 20.27, a PEG ratio of 1.58 and a beta of 0.87.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The firm had revenue of $377.41 million for the quarter, compared to the consensus estimate of $376.24 million. During the same period in the previous year, the business earned $1.49 EPS. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. Analysts expect that Addus HomeCare Corporation will post 6.3 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the sale, the insider owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 4.10% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.